John C Thomas's Net Worth
$2.6 Million
Who is John C Thomas?
John C Thomas has an estimated net worth of $2.6 Million. This is based on reported shares across multiple companies, which include Medovex Corp., Alynx, Co., NantKwest, Inc., NOVELION THERAPEUTICS INC., Virios Therapeutics, Inc., and DARA BioSciences, Inc..
SEC CIK
John C Thomas's CIK is 0001424620
Past Insider Trading and Trends
2015 was John C Thomas's most active year for acquiring shares with 4 total transactions. John C Thomas's most active month to acquire stocks was the month of May. 2019 was John C Thomas's most active year for disposing of shares, totalling 7 transactions. John C Thomas's most active month to dispose stocks was the month of May. 2016 saw John C Thomas paying a total of $60,016.37 for 343,725 shares, this is the most they've acquired in one year. In 2020 John C Thomas cashed out on 122,592 shares for a total of $1,228,564.29, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Medovex Corp. (IVRN) Snapshot price: $0.05
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +5.46% | 6K |
$0.70 | $4,200.00 | 115.96K |
Dec 15
| |||
Form 4
| -4.92% | -6.00K |
$0.70 | -$4,200.00 | 115.96K |
Dec 15
| |||
Form 4
| +13.20% | 12.82K |
$1.17 | $15,000.57 | 109.96K |
Oct 30
| |||
Form 4
| +28.83% | 21.74K |
$1.38 | $29,999.82 | 97.14K |
Jan 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Alynx, Co. (MDXG) Snapshot price: $7.78
CFO & Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NantKwest, Inc. (IBRX) Snapshot price: $4.22
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -17.03% | -42.59K |
$10.83 | -$461,122.29 | 207.48K |
Scheduled
|
Dec 10
| ||
Form 4
| -7.41% | -20.00K |
$9.19 | -$183,800.00 | 250.07K |
Aug 19
| |||
Form 4
| -18.18% | -60.00K |
$9.73 | -$583,642.00 | 270.07K |
Aug 11 - Aug 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
| -8.33% | -30.00K |
$2.87 | -$86,000.00 | 330.07K |
Scheduled
|
Dec 13 - Dec 16
| ||
Form 4
| -2.70% | -10.00K |
$1.99 | -$19,918.00 | 360.07K |
Scheduled
|
Dec 12
| ||
Form 4
| -6.09% | -24.00K |
$1.24 | -$29,789.64 | 370.07K |
Sep 5 - Sep 9
| |||
Form 4
| +30.71% | 92.59K |
—
|
—
| 394.07K |
Jun 6
| |||
Form 4
| +9.97% | 27.32K |
—
|
—
| 301.48K |
Jun 7
| |||
Form 4
| -1.61% | -4.50K |
—
|
—
| 274.15K |
Jan 2
| |||
Form 4
| -12.55% | -40.00K |
$7.46 | -$298,500.00 | 278.65K |
Scheduled
|
Jun 20
| ||
Form 4
| +8.05% | 23.75K |
—
|
—
| 318.65K |
Jun 9
| |||
Form 4
| -4.07% | -12.50K |
—
|
—
| 294.9K |
May 30
| |||
Form 4/A
| -2.39% | -7.72K |
$7.50 | -$57,892.50 | 315.07K |
Nov 23
| |||
Form 4
| -1.95% | -6.17K |
$7.50 | -$46,260.00 | 309.62K |
Nov 25
| |||
Form 4
| -5.96% | -20.00K |
$7.50 | -$150,000.00 | 315.79K |
Nov 22 - Nov 23
| |||
Form 4
| +478.31% | 277.73K |
$0.22 | $60,016.37 | 335.79K |
May 26
| |||
Form 4
| -21.60% | -16.00K |
—
|
—
| 58.06K |
Mar 1
| |||
Form 4
| -20.00% | -18.51K |
—
|
—
| 74.06K |
Aug 25 - Aug 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NOVELION THERAPEUTICS INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
| +208.33% | 25K |
$3.49 | $87,125.00 | 37K |
Jun 29
| |||
Form 4
| +500.00% | 10K |
—
|
—
| 12K |
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
|
∞
| 2K |
—
|
—
| 2K |
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 10
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Virios Therapeutics, Inc. (VIRI) Snapshot price: $0.3947
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
∞
| 1K |
$5.65 | $5,650.00 | 1K |
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||